Corrigendum to "Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab" [Lung Cancer 115 (2018) 71-74]
- PMID: 30459086
- DOI: 10.1016/j.lungcan.2018.11.007
Corrigendum to "Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab" [Lung Cancer 115 (2018) 71-74]
Erratum for
-
Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab.Lung Cancer. 2018 Jan;115:71-74. doi: 10.1016/j.lungcan.2017.11.019. Epub 2017 Nov 21. Lung Cancer. 2018. PMID: 29290265
Publication types
LinkOut - more resources
Full Text Sources
